欧洲机器人辅助肾移植经验:至少1年随访
本研究基于欧洲机器人泌尿学分会(ERUS)RAKT工作组的多中心前瞻性数据库,评估活体供肾机器人辅助肾移植(RAKT)术后至少1年的功能结果、移植物存活和晚期并发症。83例随访至少1年的患者中,1年时中位血清肌酐131 μmol/L、中位eGFR 57.4 mL/min/1.73m²,术后30天与1年功能无显著差异;结论认为RAKT在合适选择的受者中安全,并发症率低且移植物存活和功能良好。
要点
- 活体供肾RAKT术后1年移植物功能稳定,30天与1年肌酐和eGFR无显著差异。
- 总体操作时间和复温时间未影响1年移植物功能。
- 3例因术后第一周内大量动脉血栓形成导致移植物丢失。
核心结论
- 至少1年随访显示,活体供肾RAKT在合适选择的受者中是安全的手术,并发症率低且移植物存活和功能维持良好。
研究设计与样本
- 欧洲机器人泌尿学分会(ERUS)RAKT工作组建立的多中心前瞻性收集数据库,纳入8个欧洲中心。
- 共147例活体供肾RAKT,其中83例有至少1年随访(平均21个月,范围13-27个月)。
主要发现
- 83例中30例为女性,中位年龄43岁(范围30-75岁),中位BMI 25.3 kg/m²(范围20-40 kg/m²)。
- 83例中46例为抢先移植;中位总缺血时间116 min(范围53-377 min),中位复温时间60 min(范围35-110 min)。
- 1年随访时中位血清肌酐131 μmol/L(范围66-244 μmol/L),中位eGFR 57.4 mL/min/1.73m²(范围28-97 mL/min/1.73m²)。
- 术后30天与1年功能数据无统计学显著差异:肌酐P=0.78,eGFR P=0.91。
关键数值与推荐
- 总体手术时间和复温时间未影响1年移植物功能。
- 3例移植物丢失均因术后第一周内大量动脉血栓形成。
- 晚期并发症包括1例输尿管狭窄和1例移植物肾盂肾炎,未记录晚期血管并发症或切口疝。
临床怎么用
- 对于合适选择的终末期肾病患者,活体供肾RAKT可作为安全可行的移植方式。
- 术后早期应关注动脉血栓形成风险,本研究中3例移植物丢失发生于此。
- 术后30天肾功能可初步反映1年肾功能,两者无显著差异。
局限性
- 仅83例患者具有至少1年随访数据,样本量有限。
- 研究为多中心前瞻性数据库分析,非随机对照设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate functional results, graft survival and late complications in patients who underwent robot-assisted kidney transplantation (RAKT) and who had a minimum of 1 year of follow-up data, and to analyse the correlations between surgical data and functional results at a minimum of 1-year postoperatively and between renal function in the immediate postoperative period and after 1 year. MATERIALS AND METHODS: A common prospectively collected RAKT database was created by the European Robotic Urological Section (ERUS) RAKT working group, which included eight different European centres. In each centre RAKTs were performed with kidneys from living donors. Data on demographic variables, surgical results, graft survival, functional outcomes (creatinine and estimated glomerular filtration rate [eGFR]) on postoperative days 7 and 30 and at 1 year, and late complications were extracted from the common database. RESULTS: A total of 147 RAKTs were performed by the ERUS RAKT working group. Of the 147 patients, 83 had at least 1-year follow-up (mean [range] 21 [13-27] months). Of these 83 patients, 30 were women. The patients' median (range) age was 43 (30-75) years, body mass index was 25.3 (20-40) kg/m2 , pre-transplantation serum creatinine was 517 (198-1 414) μmol/L and estimated GFR (eGFR) was 10 (3-29) mL/min per 1.73 m2 . Of the 83 cases, 46 were pre-emptive. The median (range) overall ischaemia time was 116 (53-377) min. The median (range) rewarming time was 60 (35-110) min. At 1-year follow-up, the median (range) serum creatinine was 131 (66-244) μmol/L, with a median (range) eGFR of 57.4 (28-97) mL/min per 1.73 m2 . There was no statistically significant difference between functional data at postoperative day 30 and those at 1 year for creatinine (P = 0.78) or eGFR (P = 0.91). Regarding the correlation between the surgical data and the functional outcomes, the data showed that overall operating time and rewarming time did not affect the graft function at 1 year. Three cases of graft loss occurred as a result of massive arterial thrombosis within the first postoperative week. Late complications comprised one case of ureteric stenosis and one case of graft pyelonephritis. No late vascular complications or cases of incisional hernia were recorded. CONCLUSION: Findings at 1-year follow-up indicate RAKT from a living donor to be a safe procedure in a properly selected group of recipients. RAKT was associated with a low complication rate and there was maintenance of excellent graft survival and function. This is the first and largest study to report functional results after RAKT from a living donor with a minimum follow-up of 1 year.
引用
- Territo A, Gausa L, Alcaraz A, et al. European experience of robot-assisted kidney transplantation: minimum of 1-year follow-up. BJU Int. 2018. PMID: 29645355. doi:10.1111/bju.14247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。